DE69840495D1 - Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben - Google Patents

Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben

Info

Publication number
DE69840495D1
DE69840495D1 DE69840495T DE69840495T DE69840495D1 DE 69840495 D1 DE69840495 D1 DE 69840495D1 DE 69840495 T DE69840495 T DE 69840495T DE 69840495 T DE69840495 T DE 69840495T DE 69840495 D1 DE69840495 D1 DE 69840495D1
Authority
DE
Germany
Prior art keywords
deletes
production
pharmaceutical form
dispersion properties
rapid dispersion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69840495T
Other languages
English (en)
Inventor
Jaedeok Yoo
Sandeep Kumar
Donald C Monkhouse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Application granted granted Critical
Publication of DE69840495D1 publication Critical patent/DE69840495D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00—Products made by additive manufacturing
DE69840495T 1997-02-20 1998-02-20 Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben Expired - Lifetime DE69840495D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3828497P 1997-02-20 1997-02-20
US3888397P 1997-02-20 1997-02-20
PCT/US1998/003256 WO1998036738A1 (en) 1997-02-20 1998-02-20 Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same

Publications (1)

Publication Number Publication Date
DE69840495D1 true DE69840495D1 (de) 2009-03-12

Family

ID=26715043

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69840495T Expired - Lifetime DE69840495D1 (de) 1997-02-20 1998-02-20 Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben

Country Status (9)

Country Link
US (3) US6471992B1 (de)
EP (1) EP0973507B1 (de)
JP (3) JP4563516B2 (de)
AT (1) ATE421318T1 (de)
AU (1) AU736912B2 (de)
CA (1) CA2281473C (de)
DE (1) DE69840495D1 (de)
ES (1) ES2318869T3 (de)
WO (1) WO1998036738A1 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6471992B1 (en) * 1997-02-20 2002-10-29 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
ATE348601T1 (de) * 1998-05-18 2007-01-15 Takeda Pharmaceutical Im munde zerfallende tablette enthaltend ein benzimidazole
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
EP1301177A2 (de) * 2000-07-10 2003-04-16 Therics, Inc. Verfahren und materialien zur steuerung der wanderung einer binderflüssigkeit in ein pulver
US7014867B2 (en) * 2001-06-28 2006-03-21 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
MXPA04000209A (es) * 2001-07-10 2005-03-07 Teva Pharma Sistema de administracion para la administracion de droga de orden cero, bifasica de orden cero, ascendente o descendente.
EP1439945B1 (de) * 2001-10-29 2006-04-12 Therics, Inc. System und verfahren zum uniaxialen pressen eines gegenstandes wie eine drei-dimensional gedruckte dosierungsform
CA2463481A1 (en) * 2001-10-29 2003-05-22 Therics, Inc. Three-dimensional suspension printing of dosage forms
DE60323482D1 (de) * 2002-05-06 2008-10-23 Massachusetts Inst Technology Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
MX2007003032A (es) 2004-09-21 2007-05-21 Hypnion Inc Analogos de loxapina y metodos de uso de los mismos.
US7829000B2 (en) * 2005-02-25 2010-11-09 Hewlett-Packard Development Company, L.P. Core-shell solid freeform fabrication
US8187659B2 (en) 2006-05-02 2012-05-29 Jerry Robertson Real Estate Llc Solid medicament dosage form consumption aid
DK2041071T3 (da) 2006-06-29 2014-09-01 Kinex Pharmaceuticals Llc Biarylsammensætninger og fremgangsmåder til modulering af en kinasekaskade
WO2009051848A1 (en) 2007-10-20 2009-04-23 Kinex Pharmaceuticals, Llc Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
DK3254676T3 (en) 2009-10-30 2019-03-11 Ix Biopharma Ltd QUICK-SOLVING SOLID DOSAGE FORM
EP3195858B1 (de) * 2010-04-03 2019-08-07 Praful Doshi Medizinische vorrichtungen mit medikamenten sowie verfahren zu ihrer herstellung und verwendung
US8692001B2 (en) 2010-10-27 2014-04-08 Dynamix Pharmaceuticals Ltd. Sulfonamides for the modulation of PKM2
WO2012088438A1 (en) 2010-12-22 2012-06-28 Eutropics Pharmaceuticals, Inc. Compositions and methods useful for treating diseases
US8722636B2 (en) 2011-01-31 2014-05-13 New Market Pharmaceuticals, LLC Animal treatments
WO2012122370A2 (en) 2011-03-08 2012-09-13 Eutropics Pharmaceuticals, Inc. Compositions and methods useful for treating diseases
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
WO2012160447A1 (en) 2011-05-25 2012-11-29 Dynamix Pharmaceuticals Ltd. 3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
DK2718290T3 (en) 2011-06-07 2016-08-15 Clevexel Pharma Compositions and Methods for Modulating a Kinase
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
US9245061B2 (en) * 2012-04-25 2016-01-26 Shapeways, Inc. Weight-based identification of three dimensional printed parts
WO2013165468A1 (en) 2012-05-02 2013-11-07 New Market Pharmaceuticals Pharmaceutical compositions for direct systemic introduction
IN2014DN11205A (de) 2012-06-20 2015-10-02 Eutropics Pharmaceuticals Inc
CN109999040A (zh) 2012-08-30 2019-07-12 阿西纳斯公司 蛋白质酪氨酸激酶调节剂
US9545376B2 (en) 2013-01-23 2017-01-17 Arx, Llc Production of unit dose constructs
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
ES2688880T3 (es) * 2013-03-15 2018-11-07 Aprecia Pharmaceuticals LLC Forma de dosificación de dispersión rápida que contiene levetiracetam
WO2014144661A1 (en) * 2013-03-15 2014-09-18 Aprecia Pharmaceuticals Compny Rapidly dispersible dosage form of topiramate
EP2968354B1 (de) * 2013-03-15 2019-11-13 Aprecia Pharmaceuticals LLC Schnell zerfallende darreichungsform von oxcarbazepin
WO2014176389A1 (en) 2013-04-24 2014-10-30 Temple University - Of The Commonwealth System Of Higher Education Solid dosage form containing arabinogalactan
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
US10471497B2 (en) 2013-08-16 2019-11-12 The Exone Company Three-dimensional printed metal-casting molds and methods for making the same
US20160243621A1 (en) 2013-10-17 2016-08-25 The Exone Company Three-Dimensional Printed Hot Isostatic Pressing Containers and Processes for Making Same
EP3086921B1 (de) * 2013-12-23 2019-07-31 The Exone Company Verfahren und systeme zum dreidimensionalen drucken unter verwendung einer bindemittelflüssigkeit mit ausgestrahlten partikeln
EP3086922B1 (de) 2013-12-23 2022-03-09 The Exone Company Verfahren zum dreidimensionalen drucken unter verwendung eines mehrkomponentigen konstruktionspulvers
US20160332373A1 (en) 2013-12-23 2016-11-17 The Exone Company Methods and Systems for Three-Dimensional Printing Utilizing Multiple Binder Fluids
EP3137113A4 (de) * 2014-04-30 2017-03-22 Blaesi, Aron H. Schmelzverarbeitete polymere zelluläre darreichungsform
EP3148730A1 (de) 2014-05-29 2017-04-05 The Exone Company Verfahren zur herstellung von superlegierungsartikeln auf nickelbasis durch dreidimensionales drucken
WO2016011098A2 (en) 2014-07-17 2016-01-21 The Exone Company Methods and apparatuses for curing three-dimensional printed articles
CN107249567B (zh) 2014-11-21 2021-08-03 拜尔哈文制药股份有限公司 利鲁唑的舌下给药
WO2016089618A1 (en) 2014-12-03 2016-06-09 The Exone Company Process for making densified carbon articles by three dimensional printing
KR20180014778A (ko) 2015-06-03 2018-02-09 트리아스텍 인코포레이티드 제형 및 이의 용도
EP3108874A1 (de) * 2015-06-26 2016-12-28 TRB Chemedica AG Pharmazeutische zubereitung zur anwendung am auge
US11129798B2 (en) * 2016-08-19 2021-09-28 Aron H. Blaesi Fibrous dosage form
JP2019508449A (ja) * 2016-03-18 2019-03-28 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 種々の効能を有する薬物の組み合わせ
JPWO2017175792A1 (ja) * 2016-04-06 2019-02-14 アステラス製薬株式会社 速溶出性三次元造形物、速溶出性三次元造形物用フィラメント及び速溶出性三次元造形物用材料
CN107847398B (zh) 2016-05-05 2019-05-07 南京三迭纪医药科技有限公司 控制释放的药物剂型
SG11201809669RA (en) 2016-05-20 2018-11-29 Biohaven Pharm Holding Co Ltd Use of glutamate modulating agents with immunotherapies to treat cancer
EP3497099B1 (de) 2016-08-12 2022-03-02 Athenex, Inc. Biarylzusammensetzungen und verfahren zur modulierung einer kinasekaskade
EP3529023B1 (de) 2016-10-19 2022-05-25 Shapeways, Inc. Systeme und verfahren zur identifizierung dreidimensionaler druckobjekte
BR112019013503A2 (pt) 2016-12-31 2020-01-07 Bioxcel Therapeutics, Inc. Uso de dexmedetomidina sublingual para o tratamento da agitação
WO2018156141A1 (en) * 2017-02-24 2018-08-30 Hewlett-Packard Development Company, L.P. Three-dimensional (3d) printing a pharmaceutical tablet
EP3592337B1 (de) 2017-03-08 2023-07-05 Cinrx Pharma, LLC Pharmazeutische formulierungen von phloroglucinol und trimethylphloroglucinol
US10435576B2 (en) 2017-05-26 2019-10-08 Infinite Material Solutions, Llc Water soluble polymer compositions
SG11202004332XA (en) 2017-11-12 2020-06-29 Biohaven Pharm Holding Co Ltd Use of riluzole prodrugs to treat ataxias
CN108066302B (zh) * 2017-12-28 2020-09-11 无限极（中国）有限公司 一种快速分散固体制剂的制备方法及制备的快速分散固体制剂
US10350822B1 (en) 2018-01-09 2019-07-16 Triastek Inc. Dosage forms with desired release profiles and methods of designing and making thereof
CN116270513A (zh) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
DE102018107585B3 (de) * 2018-03-29 2019-03-28 Universität Rostock Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen
AU2019295699A1 (en) 2018-06-27 2021-01-28 Arx, Llc Film formulations containing dexmedetomidine and methods of producing them
AU2019359810A1 (en) 2018-10-15 2021-06-03 Aprecia Pharmaceuticals LLC Method and system for forming a dosage form within a packaging
EP3883546A1 (de) 2018-11-21 2021-09-29 Rosemont Pharmaceuticals Ltd Orale topiramat-suspensionsformulierungen mit verlängerter lagerstabilität und verbesserter bioverfügbarkeit
JP7287032B2 (ja) 2019-03-20 2023-06-06 株式会社リコー シート、シート積層体、医薬品、シートの製造方法、及びシート積層体の製造方法
EP3972567A1 (de) * 2019-05-21 2022-03-30 DFE Pharma GmbH & Co. KG Dreidimensionales laktosepulverbettdrucken
MX2022000709A (es) 2019-07-19 2022-05-19 Bioxcel Therapeutics Inc Regimenes de tratamiento con dexmedetomidina no sedante.
TWI734309B (zh) * 2019-12-19 2021-07-21 水星生醫股份有限公司 滲透性噴塗製作藥錠裝置
JP2023533478A (ja) 2020-06-26 2023-08-03 アプレシア・ファーマスーティカルズ・エルエルシー 内部空洞を有する迅速口内分散可能な錠剤
JP2023550274A (ja) 2020-10-30 2023-12-01 トリアステック インコーポレイテッド 胃滞留型医薬剤形

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4642903A (en) 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US4855326A (en) 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
FR2647343B1 (fr) * 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5204055A (en) 1989-12-08 1993-04-20 Massachusetts Institute Of Technology Three-dimensional printing techniques
US5578322A (en) 1990-11-30 1996-11-26 Yamanouchi Pharmaceutical Co., Ltd. Quick release coated preparation
ATE131111T1 (de) 1991-01-31 1995-12-15 Texas Instruments Inc Verfahren und vorrichtung zur rechnergesteuerten herstellung von dreidimensionalen gegenständen aus rechnerdaten.
US5516530A (en) * 1991-12-20 1996-05-14 Pfizer Inc. Porous shaped delivery devices and method of producing thereof
JP2521612B2 (ja) * 1992-05-20 1996-08-07 ウエイ・ミン・フアーマシユーテイカル・マニユフアクチヤリング・カンパニー・リミテツド 直接錠剤形成助剤
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5380473A (en) 1992-10-23 1995-01-10 Fuisz Technologies Ltd. Process for making shearform matrix
DE4303846A1 (de) * 1993-02-10 1994-08-11 Merck Patent Gmbh Verfahren zur Herstellung einer S-Ibuprofen enthaltenden Tablette
EP0804170B1 (de) * 1993-07-09 2001-11-14 R.P. Scherer Corporation Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
US5490962A (en) 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US6176874B1 (en) 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
US6280771B1 (en) 1997-02-20 2001-08-28 Therics, Inc. Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof
US5503785A (en) 1994-06-02 1996-04-02 Stratasys, Inc. Process of support removal for fused deposition modeling
US5633021A (en) 1994-10-19 1997-05-27 Bpm Technology, Inc. Apparatus for making a three-dimensional article
US5607697A (en) 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
US5560927A (en) * 1995-07-28 1996-10-01 Isp Investments Inc. Co-processing method for making a free-flowing compressible powder and tablet therefrom
US5653925A (en) * 1995-09-26 1997-08-05 Stratasys, Inc. Method for controlled porosity three-dimensional modeling
US6471992B1 (en) * 1997-02-20 2002-10-29 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
DE19940944B4 (de) * 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen

Also Published As

Publication number Publication date
JP2010120938A (ja) 2010-06-03
US9114072B2 (en) 2015-08-25
EP0973507B1 (de) 2009-01-21
AU736912B2 (en) 2001-08-02
EP0973507A4 (de) 2006-08-23
JP4563516B2 (ja) 2010-10-13
US20030133975A1 (en) 2003-07-17
CA2281473A1 (en) 1998-08-27
ATE421318T1 (de) 2009-02-15
JP2009215305A (ja) 2009-09-24
CA2281473C (en) 2007-01-16
AU6331498A (en) 1998-09-09
JP5091910B2 (ja) 2012-12-05
ES2318869T3 (es) 2009-05-01
WO1998036738A1 (en) 1998-08-27
US6471992B1 (en) 2002-10-29
US9463160B2 (en) 2016-10-11
EP0973507A1 (de) 2000-01-26
US20120207929A1 (en) 2012-08-16
JP2001512488A (ja) 2001-08-21

Similar Documents

Publication Publication Date Title
DE69840495D1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
DE69704426T2 (de) Verfahren zur herstellung von medizinischem kaugummi mit einem guten geschmack, enthaltend eine einschlussverbindung
DE10224607B4 (de) Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
ATE260651T1 (de) Pharmazeutische ciclosporin-formulierung mit verbesserten biopharmazeutischen eigenschaften, erhöhter physikalischer qualität & stabilität sowie verfahren zur herstellung
ATE204468T1 (de) Mittel zur verzögerten freisetzung von menschlichem wachstumshormon
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
YU66600A (sh) Farmaceutski preparati koji mogu da budu gelirani
IL76256A (en) Controlled-release medical preparations and method for their preparation
DE3850823T2 (de) System zur Freisetzung von Medikamenten und dessen Herstellungsmethode.
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
ES2094781T3 (es) Composicion farmaceutica de microparticulas con liberacion controlada y su proceso de preparacion.
ATE375729T1 (de) Verfahren zur herstellung eines pharmazeutischen kaugummis
GR3018970T3 (en) Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions.
ATE20518T1 (de) Trockene pulverige allergenzusammensetzung und verfahren zu deren herstellung.
ATE149826T1 (de) Verfahren zur herstellung von festen pharmazeutischen retardformen
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
ATE249819T1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
DE69527711D1 (de) Verfahren und apparat zur herstellung von schnelllöslichen dosierungseinheiten und daraus erhältliches produkt
ATE282406T1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
UA60352C2 (uk) Синтетичні полісахариди та фармацевтична композиція, що їх містить
Reiz et al. EMLA--a eutectic mixture of local anaesthetics for topical anaesthesia
ATA379182A (de) Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
DE60000286T2 (de) Lipide enthaltende sojaextrakte, verfahren zu deren herstellung und pharmazeutische und kosmetische zusammensetzung
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition